Basel Medical Group Ltd
BMGL
$2.02
-$0.17-7.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -118.90K | -120.20K | 275.70K | 278.40K | 491.60K |
| Total Depreciation and Amortization | 131.80K | 133.30K | 97.40K | 98.30K | 98.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.10K | -96.10K | -94.20K | -95.10K | 62.10K |
| Change in Net Operating Assets | -1.34M | -1.35M | 595.00K | 600.80K | -598.70K |
| Cash from Operations | -1.42M | -1.44M | 873.80K | 882.40K | 53.30K |
| Capital Expenditure | -6.90K | -7.00K | 0.00 | 0.00 | -2.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.40K | 20.60K | -- | -- | -- |
| Cash from Investing | 13.50K | 13.60K | 0.00 | 0.00 | -2.90K |
| Total Debt Issued | 2.21M | 2.21M | 136.80K | 136.80K | 228.70K |
| Total Debt Repaid | -2.71M | -2.71M | -682.00K | -682.00K | -779.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.13M | 5.13M | -133.80K | -133.80K | 345.90K |
| Cash from Financing | 3.47M | 3.51M | -501.70K | -506.60K | -151.90K |
| Foreign Exchange rate Adjustments | -4.50K | -4.60K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.06M | 2.08M | 372.20K | 375.80K | -101.50K |